Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2437791 Title: POTENTIALISATION DE TRAITEMENTS DE MALADIES AUTO-IMMUNES ET INFLAMMATOIRES PAR DES ANTAGONISTES OLIGONUCLÉOTIDIQUES RÉGULATEURS IMMUNS (IRO) DE TLR7 ET DE TLR9

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
107839334
WO application number:
US2010036923
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2437791
WO publication number:
WO2010141483
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
01/06/2010
Grant date:
22/03/2017
EP publication date:
11/04/2012
WO publication date:
09/12/2010
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
22/03/2017
EP B1 publication date:
22/03/2017
EP B2 publication date:
EP B3 publication date:
Lapsed date:
30/06/2017
Expiration date (if granted and all annual fees paid):
01/06/2030

Applicant

Name:
Idera Pharmaceuticals, Inc.
Legal Form:
From:
22/03/2017
Address:
167 Sidney Street, Cambridge, MA 02139, United States (US)
To:

Inventor

1

Name:
ZHU, Fu-Gang
Legal Form:
Address:
Bedford, MA 01730, United States (US)

2

Name:
KANDIMALLA, Ekambar, R.
Legal Form:
Address:
Hopkinton, MA 01748, United States (US)

3

Name:
AGRAWAL, Sudhir
Legal Form:
Address:
Shrewsbury, MA 01545, United States (US)

Priority

Priority patent number:
182928 P
Priority date:
01/06/2009
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 48/00; A61K 39/395;

Publication

Bulletin

1

Bulletin heading:
VRV
Journal edition number:
2018/09
Publication date:
04/06/2018
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

2

Bulletin heading:
EP2
Journal edition number:
2017/03b
Publication date:
16/09/2019
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
201712
Publication date:
22/03/2017
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type